Knome

Today GENALICE and Knome, Inc. USA jointly announced a strategic partnership to offer their products together as a turn-key solution for those using next-generation sequencing (NGS) data to interpret patients’ genomes.

Today GENALICE and Knome, Inc. USA jointly announced that the Swiss Foundation for People with Rare Diseases has chosen to use their solutions in tandem to improve the Foundation’s processing and analysis of their Next-Generation Sequencing (NGS) data.

Knome announced today that it has joined the Global Alliance for Genomics and Health, an alliance working to accelerate world-wide efforts to responsibly share and analyze large amounts of genomic and clinical data.

Knome, Inc. today announced that it has entered a sponsorship agreement with LabCentral to provide the knoSYS® Informatics and Genomic Interpretation System to startups operating in LabCentral’s facility in Kendall Square.

Version 3 of the knoSYS® Platform lowers barriers to next-generation sequencing genomic testing through scalability, automation, performance, and collaboration.